Next Article in Journal
Phytochemical Analysis, Antioxidant and Enzyme-Inhibitory Activities, and Multivariate Analysis of Insect Gall Extracts of Picea koraiensis Nakai
Previous Article in Journal
Assessing the Performance of Non-Equilibrium Thermodynamic Integration in Flavodoxin Redox Potential Estimation
Previous Article in Special Issue
Bioactive Compounds Produced by Endophytic Microorganisms Associated with Bryophytes—The “Bryendophytes”
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Microbial Secondary Metabolites via Fermentation Approaches for Dietary Supplementation Formulations

by
Alexandru Vasile Rusu
1,†,
Monica Trif
2,*,† and
João Miguel Rocha
3,4,5,*
1
CENCIRA Agrofood Research and Innovation Centre, Ion Meșter 6, 400650 Cluj-Napoca, Romania
2
Food Research Department, Centre for Innovative Process Engineering (CENTIV) GmbH, 28857 Syke, Germany
3
Universidade Católica Portuguesa, CBQF—Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal
4
LEPABE—Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, s/n, 4200-465 Porto, Portugal
5
ALiCE—Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, s/n, 4200-465 Porto, Portugal
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Molecules 2023, 28(16), 6020; https://doi.org/10.3390/molecules28166020
Submission received: 25 May 2023 / Revised: 3 August 2023 / Accepted: 9 August 2023 / Published: 11 August 2023

Abstract

:
Food supplementation formulations refer to products that are designed to provide additional nutrients to the diet. Vitamins, dietary fibers, minerals and other functional compounds (such as antioxidants) are concentrated in dietary supplements. Specific amounts of dietary compounds are given to the body through food supplements, and these include as well so-called non-essential compounds such as secondary plant bioactive components or microbial natural products in addition to nutrients in the narrower sense. A significant social challenge represents how to moderately use the natural resources in light of the growing world population. In terms of economic production of (especially natural) bioactive molecules, ways of white biotechnology production with various microorganisms have recently been intensively explored. In the current review other relevant dietary supplements and natural substances (e.g., vitamins, amino acids, antioxidants) used in production of dietary supplements formulations and their microbial natural production via fermentative biotechnological approaches are briefly reviewed. Biotechnology plays a crucial role in optimizing fermentation conditions to maximize the yield and quality of the target compounds. Advantages of microbial production include the ability to use renewable feedstocks, high production yields, and the potential for cost-effective large-scale production. Additionally, it can be more environmentally friendly compared to chemical synthesis, as it reduces the reliance on petrochemicals and minimizes waste generation. Educating consumers about the benefits, safety, and production methods of microbial products in general is crucial. Providing clear and accurate information about the science behind microbial production can help address any concerns or misconceptions consumers may have.

1. Introduction

In modern society, the subject of health is becoming more and more significant. People’s diets can have both positive and negative effects on their health. The primary goal of nutrition is to provide the body with all the nutrients it needs in order to prevent deficits and promote optimal function [1,2]. Surprisingly, consumers spend over a billion euros annually on dietary supplements. They include substances that are concentrated and meant to have a nutritional or physiological effect, and might be added to a regular diet but don’t have any medical properties. However, most consumers do not actually need to take such supplements [3,4]. Foods that are designed to have an extended and focused impact on physiological parameters in the consumer beyond their nutritional role are increasingly referred to as functional foods. Functional foods offer a positive additional health benefit or are meant to minimize the risk of disease in addition to their nutritional value [5,6].
In foods are incorporated certain substances (e.g., vitamins, minerals, bacterial cultures, unsaturated fatty acids) to positively influence one or more body functions. In contrast to food supplements, functional foods are introduced to the market in the shape of regular foods [7,8,9,10,11]. Sometimes, the term “functional foods” is interchanged with terms like “designer foods” and “nutraceuticals”. Legal definitions for “functional foods” are lacking. As a result, they are available for example on the German market as both nutritional goods, such like margarine enhanced with plant sterols, and foods for general consumption like probiotic yogurt [12,13]. To boost health, soft drinks, milk and dairy products, cereal based products, and spreadable fats are frequently fortified with additional substances. Other examples of useful functional foods include yogurts containing probiotic lactic acid bacteria, vitamin-enriched fruit juices, or omega-3 fatty acid-enriched bread [14,15,16,17].
A recent study found that the European market for food supplements was valued at USD 14.95 billion in 2019 and projected to reach USD 33.80 billion by 2027 [18]. Despite the fact that the spectrum of these foods has expanded significantly in recent years, scientific studies have been conducted to demonstrate the effectiveness of the foods’ functions developed. In principle, “functional foods” that fall under the definition of novel foods under the Novel Foods Regulation or that contain novel ingredients cannot be freely marketed; instead, they must go through a European clearance process. Since 2007, the European Health Claims Directive has required manufacturers to present scientific proof for the added health benefits of the ingredients from products [19,20].
Vitamins, dietary fibers, minerals, and other functional compounds are concentrated in supplements, and are frequently sold in pharmacies or health food stores as tablets, capsules, or liquids. Even though they have some similarities to medications, from a legal standpoint they are considered foodstuffs and, unlike medications, are not required to get a marketing authorization [21,22]. Despite the fact that food supplements (also known as dietary supplements) are foodstuffs rather than medicines, pharmacies are offering and selling a wider variety of these substances. The variety of items available is as extensive and varied as their nutritional-physiological value. Even for specialists, it can be challenging and difficult to get an overview of the scope of these products’ diversity and abundance [23,24,25].
Food supplementation formulations can be used to address specific nutritional deficiencies, support overall health and well-being, or cater to specific dietary needs. Nutrient deficiencies often happen during specific stages of life. It is important that while food supplementation formulations can be beneficial in certain cases, they should not replace a balanced diet. It is generally recommended to consult with a healthcare professional or registered dietitian before starting any new supplementation regime to ensure it aligns with individual needs and health goals. Both the onset and progression of diseases that are impacted by nutrition should be avoided [26]. It must be avoided conveying the idea that “food supplements” are required because a balanced, diverse diet would not deliver enough of certain essential nutrients [27]. Some consumers believe that taking dietary supplements or eating functional foods on occasion might mitigate the risk of an unhealthy diet. This hypothesis is not the case, and switching to a permanent healthy diet is both healthier and less expensive. Therefore, it must be made clear that food supplements should not be utilized in place of a diversified diet [28,29]. Specific amounts of dietary elements are given to the body through supplements, and these include so-called non-essential compounds such as secondary plant bioactive components or microbial natural products in addition to nutrients in the narrower sense [30,31,32].
Dietary supplements contain different nutrients, such as vitamins, minerals, herbs, or other botanicals, amino acids, enzymes, or other substances, intended to supplement the diet (Figure 1), and can be incorporated in various final products forms, as already mentioned, including pills, capsules, tablets, liquids, powders, and even energy bars.
There are some key aspects to keep in mind about dietary supplements [33,34,35]:
-
Supplementation: Dietary supplements are meant to complement a person’s diet when it may be difficult to obtain all necessary nutrients through food alone. They aim to fill nutritional gaps and provide additional nutrients that may be lacking;
-
Nutrient types: Common nutrients found in dietary supplements include vitamins (such as vitamin C, vitamin D, or B-complex vitamins), minerals (like calcium, iron, or magnesium), and herbal or botanical extracts (such as ginkgo biloba or Echinacea);
-
Regulation: In many countries, dietary supplements are regulated as a category of food, rather than drugs. Regulations vary, but typically supplements must be labeled accurately and must not make false or misleading claims about their benefits;
-
Health claims: Dietary supplements are often marketed with various health claims, but it is important to approach these claims with skepticism. While some supplements have been studied extensively and may have proven benefits, others may have limited or no scientific evidence to support their claimed effects. The safety and quality of dietary supplements can vary. It is important to choose reputable brands that adhere to good manufacturing practices. Additionally, some supplements may interact with medications or have adverse effects, so it’s wise to consult a healthcare professional before starting any new supplement regimen;
-
Individual needs: Not all individuals require dietary supplements. In general, it is best to obtain nutrients through a balanced diet rich in fruits, vegetables, whole grains, lean proteins, and healthy fats. However, certain population groups, such as pregnant women, older adults, or individuals with specific dietary restrictions, may benefit from targeted supplementation under the guidance of a healthcare professional.
Common types of food supplementation formulations are listed below [36,37,38,39,40,41]:
(I)
Multivitamins: These formulations contain a combination of essential vitamins and minerals to support general health; their aim is to provide a comprehensive range of nutrients that may be lacking in a person’s diet.
(II)
Omega-3 fatty acids: Omega-3 supplements often come in the form of fish oil or algae oil capsules. They provide essential fatty acids, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are beneficial for heart health, brain function, and inflammation reduction.
(III)
Protein supplements: These formulations are popular among athletes, bodybuilders, and individuals who may have increased protein needs. Protein supplements often come in powder form, are made from sources such as whey, casein, soy, or pea protein, and can be used to support muscle growth, recovery, and overall protein intake.
(IV)
Calcium and vitamin D: These supplements are commonly taken to support bone health. Calcium is essential for strong bones, while vitamin D aids in calcium absorption.
(V)
Iron supplements: Iron is crucial for the production of red blood cells and oxygen transport in the body. Iron supplementation is often recommended for individuals with iron deficiency or increased iron needs, such as pregnant women or those with certain medical conditions.
(VI)
Probiotics: Probiotic supplements contain beneficial bacteria that support a healthy gut microbiome. They can help improve digestion, boost immune function, and promote overall gut health.
(VII)
Herbal supplements: These formulations contain various plant extracts or botanical ingredients. Herbal supplements are often used to support specific health goals or address certain conditions, but their effectiveness and safety may vary.
Even if it is not always obvious, biotechnology is becoming increasingly vital in everyday life. Biotechnology is used in the production of many products, such as the homemade, meals, medications, and chemicals. These include a variety of commodities, such as bread, cheese, beer, and wine, for which people have relied on the power of live microorganisms for ages [42,43,44].
Biotechnological approaches are increasingly being used to produce microbial secondary metabolites (Figure 2) [45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60]:
Strain improvement: Microbial strains can be genetically modified or selected through breeding techniques to enhance the production of desired secondary metabolites. This can involve techniques such as mutagenesis, recombinant DNA technology, or genome editing to manipulate the metabolic pathways of microorganisms.
Fermentation optimization: Fermentation processes can be optimized to maximize the production of secondary metabolites. This includes optimizing the culture conditions such as temperature, pH, oxygen levels, and nutrient availability. Additionally, fed-batch or continuous fermentation strategies can be employed to enhance productivity.
Metabolic engineering: Metabolic engineering involves manipulating the metabolic pathways of microorganisms to redirect their metabolic flux towards the production of specific secondary metabolites. This can be achieved by overexpressing key enzymes; deleting or downregulating competing pathways; or introducing genes from other organisms to enhance productivity.
Synthetic biology: Synthetic biology techniques enable the design and construction of novel genetic circuits in microorganisms to produce specific secondary metabolites. This approach involves combining genetic parts, such as promoters, regulatory elements, and enzymes, to create new metabolic pathways or enhance existing ones.
Co-cultivation and co-culture systems: Co-cultivation involves growing multiple microbial strains together to take advantage of their synergistic interactions for secondary metabolite production. This approach allows for the exchange of metabolites, signaling molecules, or co-factor regeneration between different strains, leading to increased yields or the production of new metabolites.
Heterologous expression: Heterologous expression involves transferring the genes responsible for secondary metabolite production from one microorganism to another host organism, such as bacteria or yeast, which can be more amenable to large-scale production. This approach allows for the production of secondary metabolites that are not naturally produced by the host organism.
Genome mining and bioinformatics: Genome mining involves the identification of potential secondary metabolite gene clusters in the genomes of microorganisms using bioinformatics tools. This approach helps in the discovery of new compounds and facilitates the characterization of the biosynthetic pathways involved in their production.
These biotechnological approaches offer great potential for the production of microbial secondary metabolites. They allow for the optimization and scale-up of production processes, as well as the discovery and production of new bioactive compounds with various applications in medicine, agriculture, and industry.
The objective of the current review is to briefly summarize other relevant dietary supplements and natural substances (e.g., vitamins, amino acids, antioxidants) used in the production of dietary supplements formulations and their microbial natural production via fermentative biotechnological approaches.

2. Biotechnological Production’ Role in the Context of Sustainable Microbial Natural Products

Biotechnology plays a significant role in the development and production of microbial-sourced dietary supplementation formulations. Microbial-sourced dietary supplements typically involve the use of microorganisms, such as bacteria, yeast, or fungi, to produce beneficial compounds that can be used to enhance human health or nutrition. Biotechnology plays a vital role in harnessing the capabilities of microorganisms to produce beneficial compounds for dietary supplementation. It enables the development of more efficient, scalable, and safe processes for the production of microbial-sourced dietary supplements, contributing to advancements in the field of nutritional and functional food products.
White biotechnology approaches have become an integral part of manufacturing processes in the creation of high-quality in different industries and applications such as chemicals, medications, vitamins, detergents and cleaning agents, textile, leather, and paper finishing, and the production of many other common products. White biotechnology, well-known as industrial biotechnology, is a subfield of biotechnology. It is the application of scientific and technological knowledge to living microorganisms and their products [45,46,47].
Living microorganisms have been employed to make cheese, sourdough bread, and wine, and produce an alcoholic beer-like drink from germinated barley since the dawn of civilization. Long before the discovery of microorganisms or the comprehension of the underlying mechanisms, many cultures had developed techniques for fermenting sweet foods into alcohol using yeasts, or vinegar manufacture [48]. Only in the past three centuries microorganisms and the metabolic underpinnings of fermentation processes have been discovered [49,50]. Pasteur’s experiments laid the groundwork for understanding fermentation and current microbiology. His discovery that “the role of the infinitely small in nature is infinitely large” helped pave the road for modern biotechnology.
On the other hand, modern biotechnology is distinguished primarily by its specific application of molecular biology techniques. This led to the development of genetic engineering, which is today a crucial component of biotechnology because it gives biotechnologists the resources that they need to do their jobs thanks to the decoded molecular blueprints of living things [51]. While genetic engineering is often considered to refer to the examination and precise manipulation of an organism’s or cell’s genetic code, biotechnological processes go beyond this and integrate technical elements with cell and molecular biology, as in the case of bioprocess engineering. Organisms or specific biomolecules are employed as the foundation for industrial production in industrial biotechnology [52,53]. This makes it to be different than red (medical-pharmaceutical biotechnology) biotechnology and green (agricultural-plant biotechnology) biotechnology. When molecular biology and genetics were discovered in the latter half of the 20th century, the real scientific revolution got underway. Bioinformatics, and genome analysis in particular, have become indispensable, not only to identify the urgently needed new classes of substances, but also to fathom the molecular details of their modes of action [54].
The ability to systematically harness the productive capacities of microorganisms and cells and to analyze each of their distinct genetic components at the genetic level was only made possible by advancements in genome research. It fueled the rapid advancement of contemporary biotechnology. This is especially true in light of the identification of DNA as a hereditary molecule and the potential for targeted genetic modification [55,56]. The evolutionary metabolic variety of living nature could now be particularly utilized for industrial processes thanks to this knowledge. Science will then be able to comprehend how nature creates diversity and how this diversity may be applied to procedures employed in industrial production [57].
The resources found in nature have drawn more and more of society’s attention as a result of the need for a sustainable economy. Politic initiatives and industry sector have come to realize that current industrial practices cannot guarantee the long-term preservation of natural resources for future generations Above all, the limited availability of fossil fuels and other basic materials prompted reconsideration and accelerated the search for substitutes [58]. Since then, microorganisms create a rich but not fully explored reservoir of several natural compounds with a broad spectrum of biological. The limitless diversity of nature has just recently been understood, which is one of the reasons why the potential is so immense [59]. Scientists search every imaginable ecosystem of potential applications, including soils from all over the world, water, and sediments from the deep sea to desert sands. There are a variety of microorganisms that number anywhere between 100 million and more, according to scientists. Only 1% of them can now be distinguished by microbiologists. To gain an understanding of the enormous diversity, scientists have become experts in analyzing and deciphering microbial genomes. There are now hundreds of decoded microbe genomes available, but the potential remains far from being fully explored given the thousands of described and undiscovered microorganisms [60,61].
Microbial natural products have gained significant attention in recent years due to their potential applications as supplements. These products are derived from microorganisms such as bacteria, fungi, actinomycetes, and so-called secondary metabolites. Secondary metabolites are not essential for microbial growth but are typically produced during specific growth phases or in response to environmental stimuli. Secondary metabolites have diverse chemical structures and functions; many of them have demonstrated potential benefits for human health, making them valuable sources of bioactive compounds for various applications, including food supplements and functional foods [54,59].
For instance, some secondary metabolites produced by microbes have antimicrobial properties, which can help combat pathogenic bacteria and fungi [61]. Other secondary metabolites, such as certain polyphenols, flavonoids, and alkaloids, have been found to possess antioxidant, anti-inflammatory, and anticancer activities. Additionally, microbial metabolites can interact with the human immune system and modulate immune responses. They can influence the development and regulation of the immune system, potentially impacting immune-related diseases and disorders [62,63].
Microorganisms can be genetically engineered to produce alternative proteins that mimic the taste and texture of animal-based proteins. These proteins, such as those derived from bacteria or fungi, can serve as plant-based alternatives in various food products, including meat substitutes, dairy alternatives, and protein supplements. Another application of biotechnology in microbial-sourced dietary products is the production of enzymes. Microorganisms can be engineered to produce specific enzymes that aid in food processing and digestion. Moreover, biotechnology enables the development of microbial strains with enhanced nutritional profiles. Microbes can be genetically modified to produce higher levels of certain nutrients, such as vitamins, minerals, or essential amino acids. These nutrient-enriched microbial strains can be used as food additives or functional ingredients to improve the nutritional content of various dietary products.
Biotechnology offers valuable tools for the development and production of microbial-sourced dietary products. It enables the creation of novel ingredients, enhances nutritional profiles, improves food processing, and contributes to the growth of the alternative protein market. These advancements in biotechnology have the potential to provide sustainable and nutritious options for consumers, while reducing the environmental impact associated with traditional food production methods. Research into microbial metabolites and their effects on human health is an active and expanding field. While many potential benefits have been identified, further studies are needed to fully understand the mechanisms of action and to explore their potential therapeutic applications. In the current review other relevant dietary supplements (rather than protein, carbohydrates, etc.) used in production of dietary supplements and microbial natural produced via fermentative biotechnological approaches are reviewed.

3. Microbial Natural Products via Fermentation and Their Potential Applications for Dietary Supplements Formulations

White (industrial) biotechnology is a crucial pillar of the bioeconomy, which is a system of sustainable management based on biological resources [58,64].
The fact that biotechnological procedures can frequently be carried out under moderate, ecologically acceptable circumstances gives them an advantage over chemical processes. While chemical reactions require high temperatures and pressures, microorganisms may change complicated substances with high yields at ambient temperature and normal pressure. Therefore, industrial biotechnology is always associated with ecological expectations, many of which have already been met. However, advancements have recently started in many other application areas, particularly in the manufacturing of products from renewable raw materials [65]. Although they are usually invisible to the naked eye, bacteria, fungi, and viruses play a crucial role in life on our planet. In the global cycle of carbon and nitrogen, microorganisms are irreplaceable. Many examples show how much dependency on microorganisms is in our everyday lives and also in industry. Since only a fraction of the microorganisms on Earth are known so far, research into “microbial dark matter” holds great potential for new discoveries and their use by humans. Microorganisms play a central role in nature’s material cycle, and the increased use of microorganisms also offers great opportunities in the establishment of a sustainable, bio-based economy [66,67]. Biotechnology plays a crucial role in optimizing fermentation conditions to maximize the yield and quality of the target compounds. Factors such as temperature, pH, oxygen availability, nutrient composition, and process scale-up are carefully controlled to achieve optimal product formation. Vitamins, minerals, essential amino acids (and especially branched-chain amino acids, or BCAAs), enzymes, or plant extracts are just a few of the numerous nutrition supplements available on the market (Figure 1). These essential metabolites are needed for microbial growth, reproduction, and basic cellular functions are crucial for the survival and growth of microorganisms, and some of them also have direct benefits for human health and are often obtained through the diet or microbial synthesis in the gut. Each of them has a unique health benefit, but however, there is currently little evidence to support the majority of these supplements’ efficacy [68,69,70].

3.1. Microbial Production of Essential Amino Acids

Amino acids are one of a large family of products that are predominantly produced by various types of microorganism such as bacteria. They are the building blocks of proteins, which make up a large part of almost all cells and accelerate or catalyze the biochemical processes of life. Proteins consist of 21 different amino acids, of which humans and animals can only produce 12 themselves [40,71]. The remaining nine essential amino acids (histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan and valine) must be ingested with food [72]. Biotechnologically produced amino acids play an important role in the direct administration of nutrients into the bloodstream, i.e., bypassing the intestine, the so-called parenteral nutrition of humans. They are also important in animal nutrition [40]. Amino acid demand is increasing not only for dietary supplements, but in market areas such as animal feed, health foods, pharmaceutical precursors, artificial sweeteners, and cosmetics as well. The most important role of essential amino acids can be described as [73,74,75]:
-
Histidine is an essential amino acid involved in various metabolic pathways and protein synthesis;
-
Lysine is an essential amino acid required for protein synthesis and growth in many microorganisms;
-
Isoleucine, Leucine, and Valine (Branched-chain amino acids, or BCAAs) are essential amino acids that are important for protein synthesis and energy metabolism. L-valine and L-isoleucine, are frequently utilized as fitness supplements and for individuals with hepatic encephalopathy;
-
Methionine is an essential amino acid that is important for protein synthesis, methylation reactions, and sulfur metabolism;
-
Phenylalanine is an essential amino acid that serves as a precursor for the synthesis of other important molecules, such as tyrosine and various neurotransmitters;
-
Threonine is an essential amino acid that plays a crucial role in protein synthesis and the maintenance of healthy cells;
-
Tryptophan is an essential amino acid needed for protein synthesis and various physiological processes.
Microbial production of amino acids has gained significant attention and commercial application due to its efficiency and sustainability compared to traditional chemical synthesis methods. Amino acid synthesis by microorganisms is either fermentative or enzymatic. Amino acids are sometimes produced in quantities of several million tons per year. Microorganisms currently employed for the industrial production of amino acids were created by selection or “brute force” screening procedures after mutation programs. This method of strain enhancement has been surprisingly effective in creating organisms that produce levels of amino acids that are important to industry [76].
Methionine, threonine, and isoleucine are also produced by a branching process in bacteria that also produces lysine. Escherichia coli is one example of an organism that closely regulates this mechanism [77]. Microorganisms such as Corynebacterium glutamicum-gram-positive bacterium, through genetic–metabolic engineering is commonly used in industrial fermentation processes for the large-scale production of the amino acid L-lysine (member of the aspartate family of amino acids), but also l-glutamate family amino acids (GFAAs) (l-glutamate, l-arginine, l-citrulline, l-ornithine, l-proline, l-hydroxyproline, γ-aminobutyric acid, and 5-aminolevulinic acid) [76,77,78]. By comparing a high generating strain with the wild-type strain, genome-based strain reconstruction was employed to improve the lysine production rate of C. glutamicum [79]. L-glutamate is the most important amino acid produced followed by L-lysine.
Large-scale fermentation processes are employed to cultivate the bacterium under controlled conditions, providing it with the necessary nutrients and optimal growth environment. As the bacterium grows and metabolizes the carbon source, it produces and excretes amino acids into the fermentation broth. The accumulated amino acids can then be isolated and purified for various uses, including food additives, pharmaceuticals, and other industrial applications [80,81]. The specific extraction methods can vary depending on the type of bacteria, the amino acids of interest, and the desired level of purity. Optimization of the extraction protocol is often required to achieve the best results for a particular application. Amino acids can be extracted from bacteria using various commonly used techniques [80,81,82,83,84,85,86,87,88,89,90,91,92,93,94]:
(a)
Cell Disruption: The first step in extracting amino acids from bacteria is to disrupt the bacterial cells to release their contents. This can be achieved through mechanical disruption methods such as sonication (using ultrasonic waves), homogenization (using a blender or homogenizer), or bead beating (using glass or ceramic beads). These methods break the cell walls and release the intracellular components, including amino acids.
(b)
Filtration: After cell disruption, the resulting mixture needs to be separated to remove the cell debris and other large particles. Filtration techniques, such as centrifugation or microfiltration, can be employed to separate the liquid phase containing the extracted amino acids from the solid residue.
(c)
Precipitation: To concentrate and separate the amino acids from the liquid extract, precipitation methods can be used. The most common approach is to adjust the pH of the solution to the isoelectric point of the amino acids of interest, causing them to become insoluble and precipitate out. The precipitated amino acids can then be separated by centrifugation or filtration.
(d)
Chromatography: Chromatography techniques, such as ion exchange chromatography or high-performance liquid chromatography (HPLC), are often employed for further purification and separation of specific amino acids. These methods utilize the differences in charge, size, or hydrophobicity of the amino acids to separate them into individual components.
(e)
Desalting: If the extracted amino acids contain high levels of salts or other impurities, desalting steps may be necessary. It can be achieved by dialysis or using desalting columns, which remove the salts and other small molecules, leaving behind purified amino acids.
Several microorganisms have been used in the production of L-threonine. The synthesis of acetate limits E. coli’s production of L-threonine. Transductional crosses were used in Serratia marcescens to create a high threonine production by combining numerous feedback control mutations into one organism [82,83].
L-leucine production was reported in analogue-resistant mutants isolated from the glutamate-producing Bacillus (Brevibacterium) lactofermentum through random mutagenesis and then refined through additional mutagenesis stages or by applying metabolic engineering approaches to C. glutamicum [84,85].
Isoleucine production can be completed by fermentation with various bacteria such as classically derived mutants of C. glutamicum, S. marcescens, C. glutamicum ssp. flavum [85,86]. Valine, branched-chain amino acids, is used in the production of various chemicals. It is produced by engineered bacteria such as C. glutamicum or E. coli [87]. Engineered wild-type strain E. coli is able to overproduce histidine [88,89]. Methionine production has been achieved in genetically modified E. coli bacteria as well [90]. Phenylalanine, an aromatic amino acid, is used as well as a flavoring agent, and it can be produced by bacteria like E. coli or C. glutamicum [91]. Threonine production has been improved in engineered E. coli [92]. Tryptophan can be produced by bacteria such as E. coli or C. glutamicum [93,94].

3.2. Microbial Production of Essential Vitamins

Certain strains of bacteria or yeast can produce vitamins in large quantities. The manufacture of vitamins is another biotechnological approach. This approach is commonly used in industrial processes to produce vitamins that are used as dietary supplements, food additives, or in the pharmaceutical industry [95]. Like the essential amino acids, the vitamins needed by humans must also be taken in with food. The majority of vitamins are generated chemically in industry, while biotechnological methods are mostly used to produce vitamins. Dietary supplements fortified with these microbial-derived nutrients can help meet dietary requirements, particularly in individuals with specific dietary restrictions or deficiencies. Vitamins are essential for various physiological processes in the human body. These vitamins can be incorporated into food supplementation formulations to address specific nutrient deficiencies [96]. Compared to essential amino acids, the annual quantities produced are much smaller. However, the prices for the vitamins produced are significantly higher [96,97]. Vitamin extraction from microorganisms involves different processes [96,97,98,99,100,101,102,103,104,105,106,107]:
(a)
Cell disruption: Break open the bacterial cells to release the intracellular contents, including the vitamin. Cell disruption methods can include mechanical disruption (e.g., bead milling, high-pressure homogenization) or enzymatic treatments.
(b)
Filtration and clarification: After cell disruption, the resulting mixture is typically filtered to remove large debris and cell fragments. Further clarification steps, such as centrifugation or filtration through membranes, can be performed to obtain a clearer solution.
(c)
Purification: Purify the extracted vitamin from other cellular components and impurities. Various techniques can be employed, such as chromatography (e.g., column chromatography, high-performance liquid chromatography) or crystallization, depending on the specific vitamin and its properties.
(d)
Concentration and drying: Concentrate the purified vitamin solution to increase its potency. This can be performed through techniques like evaporation or freeze-drying (lyophilization) to remove the solvent and obtain a dry, stable vitamin powder.
(e)
Quality control: Perform rigorous quality control tests on the extracted and purified vitamin to ensure its potency, purity, and safety. These tests may include assays for vitamin content, impurity analysis, and microbial testing.
Of the 13 human vitamins, the following ones are produced via microorganisms: vitamin B2 (riboflavin) by either the fungus Ashbya gossypii or the bacterium Bacillus subtilis, and vitamin B12 with strains of Pseudomonas denitrificans or Propionibacterium freundenreichii, other possible producers, such as Sinorhizobium meliloti, different Lactobacillus strains and even E. coli [98,99,100,101,102].
Vitamin D, also known as cholecalciferol, can be synthesized by certain strains of yeast. Saccharomyces cerevisiae is commonly used in the industrial production of vitamin D. The yeast is genetically modified to produce a specific enzyme that enables the conversion of a precursor molecule into vitamin D [97,103]. Vitamin C, also known as ascorbic acid, can be produced through microbial fermentation. Several microorganisms, including certain strains of bacteria and yeast, are capable of synthesizing vitamin C. The most commonly used microorganism for large-scale production is Gluconobacter oxydans and Ketogulonicigenium vulgare [104]. Certain strains of bacteria, such as Bacillus subtilis, are used for the production of vitamin K2 [105,106,107].
P. freudenreichii has the capacity to synthesize other compounds, mostly propionic acid and trehalose besides vitamin B12, and this aspect can also boost its industrial appeal [108]. These are just a few examples of how microorganisms can be used to produce vitamins. The specific microbial strains, growth conditions, and fermentation processes may vary depending on the desired vitamin and the industry requirements. Microbial production of vitamins offers a sustainable and cost-effective alternative to chemical synthesis methods and helps meet the demand for these essential nutrients.

3.3. Microbial Production of Functional Compounds

A highly topical field of research in biotechnology is the microbial production of natural substances, many of which have health-promoting effects or are used for therapeutic purposes. Both microorganisms themselves such as bacteria, fungi, algae, and plants synthesize natural substances [109,110]. In the case of the latter, it is assumed that there are about 200,000 different natural substances. These compounds can include secondary metabolites, enzymes, and other bioactive substances. Microbial natural products often contain bioactive compounds with specific functional properties. These may include antioxidant, antimicrobial, anti-inflammatory, immune-modulating, or cholesterol-lowering effects. Incorporating these compounds into dietary supplements can offer targeted health benefits and support various aspects of human health [111].
Certain microbial metabolites possess antioxidant properties. Microorganisms can produce a wide range of antioxidants, such as phenolic compounds, flavonoids, and carotenoids. These compounds can help reduce oxidative stress in the body, protect cells from damage, and potentially prevent chronic diseases. Antioxidant-rich microbial natural products can be incorporated into dietary supplements or functional foods to enhance their nutritional value and provide antioxidant benefits [69,112].
While plants are traditionally known as the primary source of phytochemicals, scientists have discovered that many microorganisms such as bacteria, fungi, and algae are also capable of synthesizing these compounds [113]. Microorganisms produce phytochemicals as part of their natural metabolic processes. These compounds serve various functions for microorganisms, including defense against pathogens, competition for resources, and communication within microbial communities. Some microorganisms produce phytochemicals that have antimicrobial, antioxidant, anticancer, or other health-promoting properties. Several microbial metabolites have been identified as antioxidants and have shown potential in scavenging ROS and free radicals. These compounds can donate electrons or hydrogen atoms to neutralize free radicals and prevent oxidative damage. Furthermore, some microbial metabolites, such as certain peptides and polyphenols, have been reported to possess antioxidant properties and can inhibit oxidative processes by various mechanisms, including metal chelation, radical scavenging, and modulation of cellular antioxidant enzymes [114,115]. It is important to note that the antioxidant activity of microbial metabolites can vary depending on the specific compound, concentration, and experimental conditions. Additionally, their bioavailability and effectiveness in the human body can also be influenced by factors such as absorption, metabolism, and distribution.
Overall, microbial metabolites can serve as a valuable source of natural antioxidants, and their potential applications in medicine, food preservation, and nutraceutical industries are actively being explored. A few examples of microbial production strategies for phenolics include:
-
Bacterial production: some bacteria have the ability to produce phenolic compounds through their metabolic pathways. For instance, E. coli has been engineered to produce various phenolics, including resveratrol [116], a well-known antioxidant compound found in grapes and red wine. It was initially believed that resveratrol was only produced by plants, but later studies revealed that certain species of bacteria and fungi can also synthesize this compound (e.g., Saccharomyces cerevisiae) [117,118,119]. By introducing specific genes encoding enzymes involved in phenolic biosynthesis, researchers have successfully developed bacterial strains capable of producing these compounds;
-
Yeast production: certain strains of yeast, such as Saccharomyces cerevisiae, have been engineered to produce phenolic compounds [117,118,119]. Through genetic modifications, key enzymes involved in the phenolic biosynthetic pathway can be introduced into the yeast, enabling them to convert simple precursors into desired phenolic compounds. This approach has been employed to produce compounds like vanillin, which is a commonly used flavoring agent [120,121];
-
Fungal production: fungi are also a promising source for phenolic compound production. Filamentous fungi, such as Aspergillus, Rhizopus and Penicillium species, have been studied for their ability to produce phenolics [122], like tannins and coumarins, lignin derivatives, and flavonoids like naringenin and apigenin [123].
Optimization of culture conditions and genetic engineering approaches can be employed to enhance phenolic production in these fungi. While microbial production of phenolics holds promise, the field is still under active research, and further optimization and development are needed to enhance production yields and commercial viability [124].
Carotenoids are pigments responsible for the bright colors of fruits and vegetables. Some microorganisms, like certain strains of bacteria and fungi, produce carotenoids. In terms of economic production of—especially natural—pigments, ways of biotechnological production, specifically the production of pigments with various microorganisms, have recently been explored as an alternative to traditional methods, such as extraction from plants or chemical synthesis [125,126,127,128,129]. They are widely used in various industries, including food, pharmaceuticals, and cosmetics, due to their antioxidant and provitamin A activities.
Several microorganisms have been explored for their ability to produce carotenoids, including bacteria and fungi:
-
Escherichia coli: Genetic engineering techniques have been used to introduce carotenoid biosynthetic pathways into E. coli, enabling the production of carotenoids such as β-carotene and lycopene. [130];
-
Agrobacterium sp.: The bacterium has been engineered to produce astaxanthin, a highly valued carotenoid pigment, through the introduction of genes from other carotenoid-producing organisms. [131];
-
Paracoccus sp.: Some species of Paracoccus (e.g., Paracoccus carotinifaciens) have been found to naturally produce carotenoids such as canthaxanthin and astaxanthin [132];
-
Blakeslea trispora and Phycomyces blakesleeanus: commercially used for the production of β-carotene. It can be cultured under controlled conditions, and its carotenoid content can be enhanced by optimizing growth parameters. [133,134];
-
Neurospora crassa: Genetic engineering approaches have been applied to N. crassa to enhance its carotenoid production capacity. [135];
-
Phycomyces blakesleeanus: This fungus naturally produces β-carotene and can be cultivated to enhance carotenoid yields. [136]
Microorganisms can already produce astaxanthin in food purity are as well Xanthophyllomyces dendrorhous, Brevibacterium sp., Puccinia graminis and Sphingomonas astaxanthinbreifaciens [132,137]. Carotenoid’s production is already possible with algae and in filamentous fungi (especially Monascus species) and can be produced on a large industrial scale. Continuous advancements in biotechnology and synthetic biology are continually expanding the possibilities for microbiological production of carotenoids, offering sustainable and efficient alternatives to traditional methods [138]. The followings steps are involved in the carotenoid’s extraction process from microorganisms [138,139,140,141,142,143,144,145,146]:
(a)
Cell Disruption: Break open the harvested cells to release the carotenoids. Cell disruption methods can include physical techniques like sonication (ultrasonication), high-pressure homogenization, or mechanical methods such as bead milling or grinding. The objective is to rupture the cell walls and release the intracellular contents.
(b)
Extraction: Extract the carotenoids from the disrupted cells using an appropriate solvent. Common solvents for carotenoid extraction include organic solvents like acetone, ethyl acetate, or hexane. The choice of solvent depends on the nature of the carotenoids and their solubility properties.
(c)
Separation and Purification: After extraction, the crude extract is obtained, which may contain impurities and other unwanted compounds. Purify the carotenoid extract using techniques such as liquid–liquid extraction, chromatography (e.g., column chromatography or high-performance liquid chromatography), or filtration methods to obtain a pure carotenoid fraction.
(d)
Concentration and Drying: Concentrate the purified carotenoid solution using techniques such as rotary evaporation or nitrogen gas blowdown. Finally, dry the concentrated carotenoid solution to remove any residual solvent and obtain a dry carotenoid powder.
The specific extraction protocol may vary depending on the microorganism, the targeted carotenoids, and the intended application of the extracted pigments. Optimization of the extraction process can involve multiple experimental iterations to achieve the highest yield and purity of carotenoids.
The ability of microorganisms to synthesize such compounds is of great interest in fields such as medicine, agriculture, and biotechnology. The discovery of phytochemical production in microorganisms has expanded the potential sources of these bioactive compounds. Scientists are exploring the microbial world to identify new strains capable of producing valuable phytochemicals for various applications, including medicine, agriculture, and food production [139].
Microbes are often employed in industrial fermentation processes to produce enzymes that can be used in food supplementation. Enzymes like proteases (produced by Bacillus subtilis or Aspergillus oryzae) [140], lipases (derived from Candida rugosa or Rhizopus oryzae) [141], cellulases (derived from Trichoderma reesei or Aspergillus niger, Pseudomonas fluorescens, Bacillus subtilIs, E. coli, Serratia marcescens) [142], pectinases (produced by Aspergillus spp., Erwinia spp., Penicillium spp., Bacillus spp., Trichoderma viride, Mucor piriformis, Yarrowia lipolytica, Schizophyllum commune, Saccharomyces spp., Torulopsis kefyr, Candida pseudotropicalis spp.) [143], and amylases (produced by Bacillus licheniformis or Bacillus amyloliquefaciens) [144], can aid in the digestion and absorption of proteins, fats, and carbohydrates, respectively, and are used in various industries, including the production of biofuels, food processing, and textile manufacturing [145,146].
Overall, microorganisms have the capability to produce a wide range of natural plant substances, and their study and utilization hold great potential in fields such as medicine, agriculture, and biotechnology. Access to plant phytochemicals is problematic because isolation from the plant is very laborious due to the often-low concentration and the presence of many other natural substances, and chemical synthesis is not possible or unprofitable in many cases. Therefore, microbial production of plant-derived natural products is considered a promising alternative. In this process, the genes for plant biosynthetic pathways are expressed in suitable microorganisms.

4. Future Considerations

4.1. Aspects Related to Microbial Production

Advantages of microbial production of secondary metabolites for dietary supplements formulations include the ability to use renewable feedstocks, high production yields, and the potential for cost-effective large-scale production. Additionally, it can be more environmentally friendly compared to chemical synthesis, as it reduces the reliance on petrochemicals and minimizes waste generation [147,148,149]. As a general overview of the microbial production process for such metabolites, must be taken into consideration several aspects:
-
Selection of microorganism: Various microorganisms have been engineered or naturally occur with the ability to produce specific metabolites. Researchers select the appropriate microorganism based on its natural capabilities or modify its genetic makeup through genetic engineering techniques to enhance targeted metabolites production;
-
Substrate selection: Microorganisms require a carbon source for growth and metabolites production. Common substrates include glucose, molasses, starch, or other renewable biomass sources. The choice of substrate depends on the target metabolite and the cost-effectiveness of the production process;
-
Optimization of culture conditions: Microorganisms need specific environmental conditions to thrive and produce metabolites efficiently. Factors such as temperature, pH, oxygen levels, and nutrient availability are optimized to create an ideal growth environment for the microorganism;
-
Genetic Engineering: Genetic engineering techniques are employed to modify the metabolic pathways of microorganisms. This can involve introducing or overexpressing genes related to the metabolite biosynthesis pathway, removing competing pathways, or enhancing precursor supply. These modifications aim to increase the yield and productivity of the desired metabolite;
-
Fermentation process: The selected microorganism is cultured in a large-scale fermentation process. Fermenters provide controlled conditions for the microorganisms to grow and produce metabolites. The process typically involves batch, fed-batch, or continuous fermentation modes, depending on the specific requirements of the microorganism and the desired metabolite production;
-
Downstream processing: Once the fermentation process is complete, the metabolites need to be separated and purified from the fermentation broth. This process usually includes steps such as cell removal, filtration, precipitation, chromatography, and drying. The purification steps ensure the final product meets the required quality standards.
Advantages of microbial production of metabolites include the ability to use renewable feedstocks, high production yields, and the potential for cost-effective large-scale production. Additionally, this method can be more environmentally friendly compared to chemical synthesis, as it reduces the reliance on petrochemicals and minimizes waste generation [147].
A final essential point when considering the biodiversity of microorganisms is the fact that a large proportion of the bacteria and archaea found on Earth have never been studied before. Scientists also speak here of the so-called “microbial dark matter”. With the help of the DNA and RNA sequencing technologies available today, it has already been shown that the microbiomes of many habitats on Earth are dominated by previously uncultivated bacteria and archaea [148]. The metabolic performance of these microorganisms can so far only be predicted from the genome sequences. However, it is expected that with the help of novel cultivation approaches as well as synthetic biology methods, the metabolic capabilities of these organisms will be better researched in the future and made usable for biotechnology.
A recent trend is biotechnology from the ocean. With this respect, metabolic engineering of microorganisms is checked for development of cell factories and bioprocesses to use sustainable marine algae extracts as nutrients for further production of value-added products. Traditional biotechnology raw materials are replaced by marine macroalgae, due to their ingredients and are considered to be the latest generation of renewable raw materials [115,149].

4.2. Aspects Related to Consumers Acceptance

In general, consumers’ acceptance of dietary supplementation derived from microbial production can vary depending on various factors such as health conditions, scientific evidence, benefits that consumers perceive, personal beliefs and attitude, marketing influence, accessibility and affordability, and regulatory oversight [150,151,152] (Figure 3). Furthermore, consumer demand for sustainable and environmentally friendly products has led to the exploration of microbial production methods as alternatives to traditional manufacturing.
Consumers are more likely to accept dietary supplementation if they perceive it to provide tangible health benefits. This can include improving overall well-being, addressing specific nutrient deficiencies, supporting immune function, enhancing athletic performance, or promoting specific health outcomes like better skin or hair health.
Strong scientific evidence supporting the effectiveness and safety of a particular dietary supplement increases consumer acceptance. Studies published in reputable scientific journals, clinical trials, and expert recommendations can influence consumer perception and build trust.
Consumers with specific health conditions or deficiencies may be more inclined to accept dietary supplementation as a means to address those issues. For example, individuals with diagnosed nutrient deficiencies or certain medical conditions may be more open to taking supplements recommended by healthcare professionals.
Clever marketing strategies and endorsements from influencers or celebrities can significantly impact consumer acceptance of dietary supplements. Effective marketing campaigns that highlight potential benefits, target specific consumer groups, and promote trustworthiness and reliability can influence consumer choices.
The presence of robust regulatory oversight and quality control measures instills confidence in consumers. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA), play a crucial role in evaluating the safety, efficacy, and labeling of dietary supplements. Consumers are more likely to accept supplements that comply with such regulations and are backed by appropriate certifications.
Personal beliefs, cultural factors, and attitudes towards health and wellness can influence consumer acceptance of dietary supplementation. Some individuals may have a proactive approach to health and be more open to incorporating supplements into their routines, while others may prefer obtaining nutrients solely from whole foods.
Concerns about potential side effects and safety issues can impact consumer acceptance. Consumers are more likely to accept supplements with minimal reported side effects, well-established safety profiles, and clear dosage instructions.
The availability and affordability of dietary supplements can also affect consumer acceptance. The affordability of microbial products is an important factor influencing consumer acceptance. If supplements are readily accessible and reasonably priced, consumers may be more willing to incorporate them into their daily routines.
Ultimately, consumers’ acceptance of microbial products often depends on their taste, texture, and overall quality. Products that deliver a positive sensory experience, comparable to or better than conventional alternatives, are more likely to be embraced by consumers.
It’s important for consumers to make informed decisions about dietary supplementation and consult healthcare professionals before starting any new supplement regimen, particularly if they have pre-existing health conditions or are taking medications that could interact with the supplements. In addition, it is important to know that consumer acceptance can vary across different regions and demographics [4,153,154,155,156,157]. Conducting market research, understanding consumer preferences, and engaging in continuous dialogue with consumers can help companies gauge and respond to consumer acceptance of microbial products in general. Providing clear and accurate information about the science behind microbial production can help address any concerns or misconceptions consumers may have.

4.3. Achievements versus Limitations

Microbial-produced dietary supplements have gained significant attention due to their potential to provide health benefits. There are some existing achievements and limitations associated with microbial-produced dietary supplements. Certain microbes have the ability to produce essential nutrients such as vitamins and amino acids. Microbial-produced dietary supplements can provide a source of these vital nutrients, especially for individuals with dietary restrictions or deficiencies. While microbial-produced dietary supplements hold promise, more research is needed to understand their mechanisms of action, optimal dosages, and potential interactions with medications or existing health conditions. In addition, there are some other limitations:
-
Standardization and quality control: Ensuring consistent and reliable production of microbial-produced dietary supplements can be challenging. Variability in microbial strains, fermentation processes, and product formulation can affect the quality and efficacy of the supplements. Strict quality control measures are necessary to ensure safety and effectiveness;
-
Shelf stability: Some microbial-produced dietary supplements may have limited shelf stability due to the presence of live microorganisms. These products require proper storage and handling conditions to maintain viability and efficacy. Additionally, some supplements may require refrigeration, which can limit their accessibility and convenience;
-
Efficacy and individual variation: The efficacy of microbial-produced dietary supplements can vary among individuals. Factors such as the existing gut microbiota composition, overall health status, and individual response can influence the effectiveness of these supplements. What works for one person may not work the same way for another;
-
Regulatory considerations: The regulatory landscape for microbial-produced dietary supplements can be complex and varies across countries. Ensuring compliance with regulations and standards can be challenging for manufacturers, and the lack of standardized guidelines can create uncertainties in the industry.

5. Conclusions

Microbial production can provide solutions such as plant-based ingredients, alternative sweeteners, and vitamins, which can appeal to health-conscious and environmentally aware consumers. Modern process technology is utilized to control industrial production processes in the bioreactor in the best possible way. Currently, quality inspection of batches normally occurs only after production, which takes time and frequently results in significant losses. Biotechnologists want to be able to control and monitor the quality of bioproduction beginning with the initial stages of production. Genetic engineering might be needed to get over several bottlenecks, which might not be well welcomed by the general public, especially vegans and vegetarians who are highly worried about their dietary choices and the use of engineered microorganisms. While microbial natural compounds hold promise, further research is needed to fully understand their mechanisms of action, optimize their therapeutic potential, and ensure their safety and efficacy. When formulating food supplementation products, it’s crucial to consider the specific health benefits, stability, and safety of the microbial metabolites being used. Additionally, appropriate quality control measures should be implemented to ensure the consistency and efficacy of the final product. Researchers are actively investigating the potential dietary and nutraceutical applications of different microbial compounds for gut-related disorders. Microbial production offers unique advantages in terms of sustainability, efficiency, and versatility. Educating consumers about the benefits, safety, and production methods of microbial products is crucial.

Author Contributions

Conceptualization, M.T.; writing—original draft preparation, A.V.R. and M.T.; writing—review and editing, M.T., A.V.R. and J.M.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

This work is based on the work from COST Action 18101 SOURDOMICS—Sourdough biotechnology network towards novel, healthier, and sustainable food and bioprocesses (https://sourdomics.com/; https://www.cost.eu/actions/CA18101/, accessed on 25 May 2023), where the author M.T. and A.V.R. are members, and the author J.M.R. is the Chair and Grant Holder Scientific Representative and is supported by COST (European Cooperation in Science and Technology) (https://www.cost.eu/, accessed on 25 May 2023). COST is a funding agency for research and innovation networks. Author J.M.R. also acknowledges the Universidade Católica Portuguesa, CBQF—Centro de Biotecnologia e Química Fina—Laboratório Associado, Escola Superior de Biotecnologia, Porto, Portugal, as well as the support made by LA/P/0045/2020 (ALiCE) and UIDB/00511/2020-UIDP/00511/2020 (LEPABE) funded by national funds through FCT/MCTES (PIDDAC).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. World Health Organization. About World Health Organization. Constitution. Available online: http://www.who.int/governance/eb/constitution/en/ (accessed on 27 April 2023).
  2. Svalastog, A.L.; Donev, D.; Jahren Kristoffersen, N.; Gajović, S. Concepts and definitions of health and health-related values in the knowledge landscapes of the digital society. Croat. Med. J. 2017, 58, 431–435. [Google Scholar] [CrossRef] [Green Version]
  3. Kruk, M.E.; Gage, A.D.; Arsenault, C.; Jordan, K.; Leslie, H.H.; Roder-DeWan, S.; Adeyi, O.; Barker, P.; Daelmans, B.; Doubova, S.V.; et al. High-quality health systems in the Sustainable Development Goals era: Time for a revolution. Lancet Glob. Health 2018, 6, e1196–e1252, Erratum in Lancet Glob. Health 2021, 9, e1067. [Google Scholar] [CrossRef] [Green Version]
  4. Baker, M.T.; Lu, P.; Parrella, J.A.; Leggette, H.R. Consumer Acceptance toward Functional Foods: A Scoping Review. Int. J. Environ. Res. Public Health 2022, 19, 1217. [Google Scholar] [CrossRef]
  5. Sharma, R.; Garg, P.; Kumar, P.; Bhatia, S.K.; Kulshrestha, S. Microbial Fermentation and Its Role in Quality Improvement of Fermented Foods. Fermentation 2020, 6, 106. [Google Scholar]
  6. Shaikh, S. Sources and Health Benefits of Functional Food Components. In Current Topics in Functional Food; Shiomi, N., Savitskaya, A., Eds.; IntechOpen: London, UK, 2022. [Google Scholar] [CrossRef]
  7. Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the Approximation of the Laws of the Member States Relating to Food Supplements. 2023. Available online: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32002L0046 (accessed on 27 April 2023).
  8. EFSA. Food Supplements. 2020. Available online: http://www.efsa.europa.eu/en/topics/topic/food-supplements (accessed on 10 September 2020).
  9. Granato, D.; Barba, F.J.; Bursać Kovačević, D.; Lorenzo, J.M.; Cruz, A.G.; Putnik, P. Functional foods: Product development, technological trends, efficacy testing, and safety. Annu. Rev. Food Sci. Technol. 2020, 11, 93–118. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Bagchi, D. Nutraceutical and Functional Food Regulations in the United States and Around the World, 3rd ed.; Academic Press: London, UK, 2019. [Google Scholar]
  11. Bigliardi, B.; Galati, F. Innovation trends in the food industry: The case of functional foods. Trends Food Sci. Technol. 2013, 31, 118–129. [Google Scholar]
  12. Wortmann, L.; Enneking, U.; Daum, D. German consumers’ attitude towards selenium-biofortified apples and acceptance of related nutrition and health claims. Nutrients 2018, 10, 190. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Gonçalves, A.C.; Nunes, A.R.; Flores-Félix, J.D.; Alves, G.; Silva, L.R. Cherries and Blueberries-Based Beverages: Functional Foods with Antidiabetic and Immune Booster Properties. Molecules 2022, 27, 3294. [Google Scholar]
  14. Yang, S.-Y.; Yoon, K.-S. Effect of Probiotic Lactic Acid Bacteria (LAB) on the Quality and Safety of Greek Yogurt. Foods 2022, 11, 3799. [Google Scholar] [CrossRef] [PubMed]
  15. Moineau-Jean, A.; Champagne, C.P.; Roy, D.; Raymond, Y.; LaPointe, G. Effect of Greek-style yoghurt manufacturing processes on starter and probiotic bacteria populations during storage. Int. Dairy J. 2019, 93, 35–44. [Google Scholar] [CrossRef]
  16. Petrovna, L.G.; Vladimirovna, S.E.; Dashievna, Z.S.; Sergeevna, K.T. The Functional Properties of Bread Enriched with Essential Fatty Acids. KnE Life Sci. 2022, 7, 236–250. [Google Scholar] [CrossRef]
  17. Verni, M.; Rizzello, C.G.; Coda, R. Fermentation biotechnology applied to cereal industry by-products: Nutritional and functional insights. Front. Nutr. 2019, 6, 42. [Google Scholar]
  18. Fortune Business Insights. Europe Dietary Supplements Market Size, Trends|Analysis [2020–2027]. Market Report Research. 2019. Available online: https://www.fortunebusinessinsights.com/industry-reports/europe-dietary-supplements-market-101918 (accessed on 7 April 2023).
  19. Roobab, U.; Abida, A.; Chacha, J.S.; Athar, A.; Madni, G.M.; Ranjha, M.M.A.N.; Rusu, A.V.; Zeng, X.-A.; Aadil, R.M.; Trif, M. Applications of Innovative Non-Thermal Pulsed Electric Field Technology in Developing Safer and Healthier Fruit Juices. Molecules 2022, 27, 4031. [Google Scholar] [CrossRef] [PubMed]
  20. Provst, I. Functional foods in Europe: A focus on health claims. In Scientific, Health and Social Aspects of the Food Industry; IntechOpen: London, UK, 2012. [Google Scholar]
  21. Nasri, H.; Baradaran, A.; Shirzad, H.; Rafieian-Kopaei, M. New concepts in nutraceuticals as alternative for pharmaceuticals. Int. J. Prev. Med. 2014, 5, 1487–1499. [Google Scholar] [PubMed]
  22. Prakash, O.; Ved, A.; Kumar, S.; Kumar, R.; Mariappan, G.; Rawat, A.K.S. Exploring Role of Dietary Fibres, Nutraceuticals and Functional Foods in Cardiovascular Disorders. Curr. Top. Nutraceutical Res. 2017, 15, 67. [Google Scholar]
  23. Augustsson, A.; Qvarforth, A.; Engström, E.; Paulukat, C.; Rodushkin, I. Trace and major elements in food supplements of different origin: Implications for daily intake levels and health risks. Toxicol. Rep. 2021, 8, 1067–1080. [Google Scholar] [PubMed]
  24. Rani, V.; Yadav, U.C.S. Functional Food and Human Health; Springer: Berlin, Germany, 2018. [Google Scholar]
  25. Qin, Y. 6—Applications of Bioactive Seaweed Substances in Functional Food Products; Academic Press: Cambridge, MA, USA, 2018. [Google Scholar]
  26. Muscaritoli, M. The Impact of Nutrients on Mental Health and Well-Being: Insights from the Literature. Front. Nutr. 2021, 8, 656290. [Google Scholar] [CrossRef] [PubMed]
  27. Bechoff, A.; De Bruyn, J.; Alpha, A.; Wieringa, F.; Greffeuille, V. Exploring the complementarity of fortification and dietary diversification to combat micronutrient deficiencies: A scoping review. Curr. Dev. Nutr. 2023, 7, 100033. [Google Scholar] [CrossRef] [PubMed]
  28. Gombart, A.F.; Pierre, A.; Maggini, S. A review of micronutrients and the immune system-working in harmony to reduce the risk of infection. Nutrients 2020, 12, 236. [Google Scholar] [CrossRef] [Green Version]
  29. Hans, K.B.; Jana, T. Micronutrients in the life cycle: Requirements and sufficient supply. NFS J. 2018, 11, 1–11. [Google Scholar] [CrossRef]
  30. Vaz, B.D.S.; Moreira, J.B.; Morais, M.G.D.; Costa, J.A.V. Microalgae as a new source of bioactive compounds in food supplements. Curr. Opin. Food Sci. 2016, 7, 73–77. [Google Scholar] [CrossRef]
  31. Samtiya, M.; Aluko, R.E.; Dhewa, T.; Moreno-Rojas, J.M. Potential Health Benefits of Plant Food-Derived Bioactive Components: An Overview. Foods 2021, 10, 839. [Google Scholar] [CrossRef] [PubMed]
  32. Ghosh, S.; Sarkar, T.; Pati, S.; Kari, Z.A.; Edinur, H.A.; Chakraborty, R. Novel Bioactive Compounds from Marine Sources as a Tool for Functional Food Development. Front. Mar. Sci. 2022, 9, 832957. [Google Scholar] [CrossRef]
  33. Ali, S.; Shah, W.A.S.; Shah, M.A.; Zareef, M.; Arslan, M.; Hassan, M.; Ali, I.; Ali, M.; Ullah, S. Adulteration and Safety Issues in Nutraceuticals and Functional Foods. In Advances in Nutraceuticals and Functional Foods; Apple Academic Press: Palm Bay, FL, USA, 2022; pp. 79–103. [Google Scholar]
  34. Fogacci, F.; Fogacci, S. Cardiovascular Risk Factors Management in Pregnancy: A Role for Nutraceuticals? In Nutraceuticals and Cardiovascular Disease; Humana: Cham, Switzerland, 2021; pp. 245–253. [Google Scholar]
  35. Sirico, F.; Miressi, S.; Castaldo, C.; Spera, R.; Montagnani, S.; Di Meglio, F.; Nurzynska, D. Habits and beliefs related to food supplements: Results of a survey among Italian students of different education fields and levels. PLoS ONE 2018, 13, e0191424. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Hassan, S.; Egbuna, C.; Tijjani, H.; Ifemeje, J.C.; Olisah, M.C.; Patrick-Iwuanyanwu, K.C.; Onyeike, P.C.; Ephraim-Emmanuel, B.C. Dietary Supplements: Types, Health Benefits, Industry and Regulation. In Functional Foods and Nutraceuticals; Egbuna, C., Dable Tupas, G., Eds.; Springer: Cham, Switzerland, 2020. [Google Scholar] [CrossRef]
  37. Puri, V.; Nagpal, M.; Singh, I.; Singh, M.; Dhingra, G.A.; Huanbutta, K.; Dheer, D.; Sharma, A.; Sangnim, T. A Comprehensive Review on Nutraceuticals: Therapy Support and Formulation Challenges. Nutrients 2022, 14, 4637. [Google Scholar] [CrossRef]
  38. Vorderbruggen, M. Enhanced D Vitamin Nutraceutical Compositions and Methods for Making and Used Same. U.S. Patent 17/546,982, 16 June 2022. [Google Scholar]
  39. Ghorbanzade, T.; Jafari, S.M.; Akhavan, S.; Hadavi, R. Nano-encapsulation of fish oil in nano-liposomes and its application in fortification of yogurt. Food Chem. 2017, 216, 146–152. [Google Scholar] [PubMed]
  40. Verstringe, S.; Vandercruyssen, R.; Carmans, H.; Rusu, A.V.; Bruggeman, G.; Trif, M. Alternative Proteins for Food and Feed. In Biodiversity, Functional Ecosystems and Sustainable Food Production; Galanakis, C.M., Ed.; Springer: Cham, Switzerland, 2023. [Google Scholar] [CrossRef]
  41. Patel, P.; Jethani, H.; Radha, C.; Vijayendra, S.V.N.; Mudliar, S.N.; Sarada, R.; Chauhan, V.S. Development of a carotenoid enriched probiotic yogurt from fresh biomass of Spirulina and its characterization. J. Food Sci. Technol. 2019, 56, 3721–3731. [Google Scholar] [CrossRef]
  42. Voidarou, C.; Antoniadou, Μ.; Rozos, G.; Tzora, A.; Skoufos, I.; Varzakas, T.; Lagiou, A.; Bezirtzoglou, E. Fermentative Foods: Microbiology, Biochemistry, Potential Human Health Benefits and Public Health Issues. Foods 2021, 10, 69. [Google Scholar]
  43. Tullio, V. Yeast Genomics and Its Applications in Biotechnological Processes: What Is Our Present and Near Future? J. Fungi 2022, 8, 752. [Google Scholar] [CrossRef]
  44. Skowron, K.; Budzyńska, A.; Grudlewska-Buda, K.; Wiktorczyk-Kapischke, N.; Andrzejewska, M.; Wałecka-Zacharska, E.; Gospodarek-Komkowska, E. Two Faces of Fermented Foods—The Benefits and Threats of Its Consumption. Front. Microbiol. 2022, 13, 845166. [Google Scholar] [PubMed]
  45. Frazzetto, G. White biotechnology. EMBO Rep. 2003, 4, 835–837. [Google Scholar] [CrossRef] [PubMed]
  46. Kordi, M.; Salami, R.; Bolouri, P.; Delangiz, N.; Lajayer, B.A.; van Hullebusch, E.D. White biotechnology and the production of bio-products. Syst. Microbiol. Biomanuf. 2022, 2, 413–429. [Google Scholar] [CrossRef]
  47. Heux, S.; Meynial-Salles, I.; O’Donohue, M.J.; Dumon, C. White biotechnology: State of the art strategies for the development of biocatalysts for biorefining. Biotechnol. Adv. 2015, 33, 1653–1670. [Google Scholar] [CrossRef] [PubMed]
  48. Nout, M.J.R. Food Technologies: Fermentation. In Encyclopedia of Food Safety, Volume 3: Foods, Materials, Technologies and Risks; Elsevier: Amsterdam, The Netherlands, 2014. [Google Scholar] [CrossRef]
  49. Shaw, A.J.; Lam, F.H.; Hamilton, M.; Consiglio, A.; MacEwen, K.; Brevnova, E.E.; Greenhagen, E.; LaTouf, W.G.; South, C.R.; van Dijken, H.; et al. Metabolic engineering of microbial competitive advantage for industrial fermentation processes. Science 2016, 353, 583–586. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Pan, Y.; Wang, Y.; Hao, W.; Duan, C.; Wang, S.; Wei, J.; Liu, G. Metatranscriptomics Unravel Composition, Drivers, and Functions of the Active Microorganisms in Light-Flavor Liquor Fermentation. Microbiol. Spectr. 2022, 10, e0215121. [Google Scholar] [CrossRef] [PubMed]
  51. Parapouli, M.; Vasileiadis, A.; Afendra, A.S.; Hatziloukas, E. Saccharomyces cerevisiae and its industrial applications. AIMS Microbiol. 2020, 6, 1–31. [Google Scholar] [CrossRef] [PubMed]
  52. Li, H.; Yang, Y.; Hong, W.; Huang, M.; Wu, M.; Zhao, X. Applications of genome editing technology in the targeted therapy of human diseases: Mechanisms, advances and prospects. Sig. Transduct. Target. Ther. 2020, 5, 1. [Google Scholar] [CrossRef]
  53. Adli, M. The CRISPR tool kit for genome editing and beyond. Nat. Commun. 2018, 9, 1911. [Google Scholar] [CrossRef] [Green Version]
  54. Nielsen, J.C.; Nielsen, J. Development of fungal cell factories for the production of secondary metabolites: Linking genomics and metabolism. Synth. Syst. Biotechnol. 2017, 2, 5–12. [Google Scholar]
  55. Xu, Y.; Li, Z. CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy. Comput. Struct. Biotechnol. J. 2020, 18, 2401–2415. [Google Scholar] [CrossRef]
  56. Knott, G.J.; Doudna, J.A. CRISPR-Cas guides the future of genetic engineering. Science 2018, 361, 866–869. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Orsi, E.; Claassens, N.J.; Nikel, P.I.; Lindner, S.N. Growth-coupled selection of synthetic modules to accelerate cell factory development. Nat. Commun. 2021, 12, 5295. [Google Scholar] [CrossRef] [PubMed]
  58. Dietrich, T.; Villaran Velasco, M.C.; Echeverría, P.J.; Pop, B.; Rusu, A. Crop and Plant Biomass as Valuable Material for BBB. Alternatives for Valorization of Green Wastes. In Biotransformation of Agricultural Waste and By-Products: The Food, Feed, Fibre, Fuel (4F) Economy; Elsevier: San Diego, CA, USA, 2016. [Google Scholar]
  59. Punia Bangar, S.; Chaudhary, V.; Thakur, N.; Kajla, P.; Kumar, M.; Trif, M. Natural Antimicrobials as Additives for Edible Food Packaging Applications: A Review. Foods 2021, 10, 2282. [Google Scholar] [CrossRef] [PubMed]
  60. Berg, G.; Rybakova, D.; Fischer, D.; Cernava, T.; Vergès, M.C.; Charles, T.; Chen, X.; Cocolin, L.; Eversole, K.; Corral, G.H.; et al. Microbiome definition re-visited: Old concepts and new challenges. Microbiome 2020, 8, 103, Erratum in Microbiome 2020, 8, 119. [Google Scholar] [CrossRef] [PubMed]
  61. Bangar, S.P.; Sharma, N.; Kumar, M.; Ozogul, F.; Purewal, S.S.; Trif, M. Recent developments in applications of lactic acid bacteria against mycotoxin production and fungal contamination. Food Biosci. 2021, 44, 101444. [Google Scholar] [CrossRef]
  62. Roy, A.; Khan, A.; Ahmad, I.; Alghamdi, S.; Rajab, B.S.; Babalghith, A.O.; Alshahrani, M.Y.; Islam, S.; Islam, M.R. Flavonoids a Bioactive Compound from Medicinal Plants and Its Therapeutic Applications. Biomed. Res. Int. 2022, 2022, 5445291. [Google Scholar] [CrossRef]
  63. Abdelghani, Z.; Hourani, N.; Zaidan, Z.; Dbaibo, G.; Mrad, M.; Hage-Sleiman, R. Therapeutic applications and biological activities of bacterial bioactive extracts. Arch. Microbiol. 2021, 203, 4755–4776. [Google Scholar] [CrossRef] [PubMed]
  64. Tufail, T.; Ain, H.B.U.; Saeed, F.; Nasir, M.; Basharat, S.; Mahwish; Rusu, A.V.; Hussain, M.; Rocha, J.M.; Trif, M.; et al. A Retrospective on the Innovative Sustainable Valorization of Cereal Bran in the Context of Circular Bioeconomy Innovations. Sustainability 2022, 14, 14597. [Google Scholar] [CrossRef]
  65. Coughlan, L.M.; Cotter, P.D.; Hill, C.; Alvarez-Ordóñez, A. Biotechnological applications of functional metagenomics in the food and pharmaceutical industries. Front. Microbiol. 2015, 6, 672. [Google Scholar] [CrossRef] [Green Version]
  66. Zhang, Y.; Wang, Y.; Tang, M.; Zhou, J.; Zhang, T. The microbial dark matter and “wanted list” in worldwide wastewater treatment plants. Microbiome 2023, 11, 59. [Google Scholar] [CrossRef] [PubMed]
  67. Trif, M.; Rusu, A.V.; Francino, M.P.; Delgado, G.; Rufián-Henares, J.Á. Microbiome Applications for Sustainable Food Systems. In Biodiversity, Functional Ecosystems and Sustainable Food Production; Galanakis, C.M., Ed.; Springer: Cham, Switzerland, 2023. [Google Scholar] [CrossRef]
  68. Delompré, T.; Guichard, E.; Briand, L.; Salles, C. Taste Perception of Nutrients Found in Nutritional Supplements: A Review. Nutrients 2019, 11, 2050. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  69. Wu, Q.; Gao, Z.J.; Yu, X.; Wang, P. Dietary regulation in health and disease. Sig. Transduct. Target. Ther. 2022, 7, 252. [Google Scholar] [CrossRef]
  70. Bott, M. Nutzung mikrobieller und pflanzlicher Diversität in der Biotechnologie. In Biodiversität im Meer und an Land. Vom Wert Biologischer Vielfalt; Kandarr, J., Jorzik, O., Klinghammer, P., Spreen, D., Eds.; Deutsches GeoForschungsZentrum GFZ: Potsdam, Germany, 2020; pp. 50–53. [Google Scholar] [CrossRef]
  71. Murray, J.E.; Laurieri, N.; Delgoda, R. Chapter 24—Proteins. In Pharmacognosy; Badal, S., Delgoda, R., Eds.; Academic Press: Boston, MA, USA, 2017; pp. 477–494. [Google Scholar]
  72. Hoffer, L.J. Parenteral Nutrition: Amino Acids. Nutrients 2017, 9, 257. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  73. Parikh, P.; Semba, R.; Manary, M.; Swaminathan, S.; Udomkesmalee, E.; Bos, R.; Poh, B.K.; Rojroongwasinkul, N.; Geurts, J.; Sekartini, R.; et al. Animal source foods, rich in essential amino acids, are important for linear growth and development of young children in low- and middle-income countries. Matern. Child. Nutr. 2022, 18, e13264. [Google Scholar] [CrossRef] [PubMed]
  74. Lv, Z.; Shi, W.; Zhang, Q. Role of Essential Amino Acids in Age-Induced Bone Loss. Int. J. Mol. Sci. 2022, 23, 11281. [Google Scholar] [CrossRef] [PubMed]
  75. Endrinikapoulos, A.; Afifah, D.N.; Mexitalia, M.; Andoyo, R.; Hatimah, I.; Nuryanto, N. Study of the importance of protein needs for catch-up growth in Indonesian stunted children: A narrative review. SAGE Open Med. 2023, 11, 1–9. [Google Scholar] [CrossRef] [PubMed]
  76. Sanchez, S.; Rodríguez-Sanoja, R.; Ramos, A.; Demain, A.L. Our microbes not only produce antibiotics, they also overproduce amino acids. J. Antibiot. 2018, 71, 26–36. [Google Scholar] [CrossRef]
  77. Sanchez, S.; Demain, A.L. Bioprocess, Bioseparation, and Cell Technology EIB; Flickinger, M.C., Ed.; John Wiley and Sons: Chichester, UK, 2010; Volume 2, pp. 1186–1202. [Google Scholar]
  78. Eggeling, L.; Bott, M. A giant market and a powerful metabolism: L-lysine provided by Corynebacterium glutamicum. Appl. Microbiol. Biotechnol. 2015, 99, 3387–3394. [Google Scholar] [CrossRef] [PubMed]
  79. Becker, J.; Zelder, O.; Häfner, S.; Schröder, H.; Wittmann, C. From zero to hero-design-based systems metabolic engineering of Corynebacterium glutamicum for L-lysine production. Metabol. Eng. 2011, 13, 159–168. [Google Scholar] [CrossRef] [PubMed]
  80. Matano, C.; Uhde, A.; Youn, J.W.; Maeda, T.; Clermont, L.; Marin, K.; Kramer, R.; Wendisch, V.F.; Seibold, G.M. Engineering of Corynebacterium glutamicum for growth and L-lysine and lycopene production from N-acetyl-glucosamine. Appl. Microbiol. Biotechnol. 2014, 98, 5633–5643. [Google Scholar] [CrossRef]
  81. Sheng, Q.; Wu, X.Y.; Xu, X.; Tan, X.; Li, Z.; Zhang, B. Production of l-glutamate family amino acids in Corynebacterium glutamicum: Physiological mechanism, genetic modulation, and prospects. Synth. Syst. Biotechnol. 2021, 6, 302–325. [Google Scholar] [CrossRef] [PubMed]
  82. Xie, X.; Liang, Y.; Liu, H.; Liu, Y.; Xu, Q.; Zhang, C.; Chen, N. Modification of glycolysis and its effect on the production of L-threonine in Escherichia coli. J. Indust. Microbiol. Biotechnol. 2014, 41, 1007–1015. [Google Scholar] [CrossRef] [PubMed]
  83. Zhang, Y.; Meng, Q.; Ma, H.; Liu, Y.; Cao, G.; Zhang, X.; Zheng, P.; Sun, J.; Zhang, D.; Jiang, W.; et al. Determination of key enzymes for threonine synthesis through in vitro metabolic pathway analysis. Microb. Cell Factories 2015, 14, 86–95. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Huang, Q.; Liang, L.; Wu, W.; Wu, S.; Huang, J. Metabolic engineering of Corynebacterium glutamicum to enhance L-leucine production. Afr. J. Biotechnol. 2017, 16, 1048–1060. [Google Scholar] [CrossRef] [Green Version]
  85. Vogt, M.; Haas, S.; Klaffl, S.; Polen, T.; Eggeling, L.; van Ooyen, J.; Bott, M. Pushing product formation to its limit: Metabolic engineering of Corynebacterium glutamicum for L-leucine overproduction. Metab. Eng. 2013, 22, 40–52. [Google Scholar] [CrossRef]
  86. Ma, W.; Wang, J.; Li, Y.; Hu, X.; Shi, F.; Wang, X. Enhancing pentose phosphate pathway in Corynebacterium glutamicum to improve L-isoleucine production. Biotechnol. Appl. Biochem. 2016, 63, 877–885. [Google Scholar] [CrossRef]
  87. Oldiges, M.; Eikmanns, B.J.; Blombach, B. Applications of metabolic engineering for the biotechnological production of L-valine. Appl. Microbiol. Biotechnol. 2014, 98, 5859–5870. [Google Scholar] [CrossRef] [Green Version]
  88. Wu, H.; Tian, D.; Fan, X.; Fan, W.; Zhang, Y.; Jiang, S.; Wen, C.; Ma, Q.; Chen, N.; Xie, X. Highly Efficient Production of l-Histidine from Glucose by Metabolically Engineered Escherichia coli. ACS Synth. Biol. 2020, 9, 1813–1822. [Google Scholar] [CrossRef]
  89. Malykh, E.A.; Butov, I.A.; Ravcheeva, A.B.; Krylov, A.A.; Mashko, S.V.; Stoynova, N.V. Specific features of l-histidine production by Escherichia coli concerned with feedback control of AICAR formation and inorganic phosphate/metal transport. Microb. Cell Fact. 2018, 17, 42. [Google Scholar] [CrossRef] [PubMed]
  90. Mohany, N.A.M.; Totti, A.; Naylor, K.R.; Janovjak, H. Microbial methionine transporters and biotechnological applications. Appl. Microbiol. Biotechnol. 2021, 105, 3919–3929. [Google Scholar] [CrossRef] [PubMed]
  91. Ding, D.; Liu, Y.; Xu, Y.; Zheng, P.; Li, H.; Zhang, D. Improving the production of L-phenylalanine by identifying key enzymes through multi-enzyme reaction system in vitro. Sci. Rep. 2016, 6, 32208. [Google Scholar] [CrossRef] [Green Version]
  92. Wang, S.; Fang, Y.; Wang, Z.; Zhang, S.; Wang, L.; Guo, Y.; Wang, X. Improving l-threonine production in Escherichia coli by elimination of transporters ProP and ProVWX. Microb. Cell Fact. 2021, 20, 58. [Google Scholar] [CrossRef] [PubMed]
  93. Wang, J.; Cheng, L.; Wang, J.; Liu, J.; Shen, T.; Chen, N. Genetic engineering of Escherichia coli to enhance production of L-tryptophan. Appl. Microbiol. Biotechnol. 2013, 97, 7587–7596. [Google Scholar] [CrossRef]
  94. Ikeda, M.; Nakanishi, K.; Kino, K.; Katsumata, R. Fermentative production of tryptophan by a stable recombinant strain of Corynebacterium glutamicum with a modified serine-biosynthetic pathway. Biosci. Biotechnol. Biochem. 2014, 58, 674–678. [Google Scholar] [CrossRef] [PubMed]
  95. Wang, Y.; Liu, L.; Jin, Z.; Zhang, D. Microbial Cell Factories for Green Production of Vitamins. Front. Bioeng. Biotechnol. 2021, 9, 661562. [Google Scholar] [CrossRef] [PubMed]
  96. Brancaccio, M.; Mennitti, C.; Cesaro, A.; Fimiani, F.; Vano, M.; Gargiulo, B.; Caiazza, M.; Amodio, F.; Coto, I.; D’Alicandro, G.; et al. The Biological Role of Vitamins in Athletes’ Muscle, Heart and Microbiota. Int. J. Environ. Res. Public Health 2022, 19, 1249. [Google Scholar] [CrossRef] [PubMed]
  97. Amrein, K.; Scherkl, M.; Hoffmann, M.; Neuwersch-Sommeregger, S.; Köstenberger, M.; Berisha, A.T.; Martucci, G.; Pilz, S.; Malle, O. Vitamin D deficiency 2.0: An update on the current status worldwide. Eur. J. Clin. Nutr. 2020, 74, 1498–1513. [Google Scholar] [CrossRef] [PubMed]
  98. Acevedo-Rocha, C.G.; Gronenberg, L.S.; Mack, M.; Commichau, F.M.; Genee, H.J. Microbial Cell Factories for the Sustainable Manufacturing of B Vitamins. Curr. Opin. Biotechnol. 2019, 56, 18–29. [Google Scholar] [CrossRef] [PubMed]
  99. Calvillo, Á.; Pellicer, T.; Carnicer, M.; Planas, A. Bioprocess Strategies for Vitamin B12 Production by Microbial Fermentation and Its Market Applications. Bioengineering 2022, 9, 365. [Google Scholar] [CrossRef] [PubMed]
  100. Zhang, Y.; Li, X.; Wang, Z.; Wang, Y.; Ma, Y.; Su, Z. Metabolic Flux Analysis of Simultaneous Production of Vitamin B12 and Propionic Acid in a Coupled Fermentation Process by Propionibacterium freudenreichii. Appl. Biochem. Biotechnol. 2021, 193, 3045–3061. [Google Scholar] [CrossRef] [PubMed]
  101. Liu, J.; Liu, Y.; Wu, J.; Fang, H.; Jin, Z.; Zhang, D. Metabolic Profiling Analysis of the Vitamin B12 Producer Propionibacterium freudenreichii. Microbiologyopen 2021, 10, e1199. [Google Scholar] [CrossRef] [PubMed]
  102. Wang, P.; Shen, C.; Li, L.; Guo, J.; Cong, Q.; Lu, J. Simultaneous Production of Propionic Acid and Vitamin B12 from Corn Stalk Hydrolysates by Propionibacterium freudenreichii in an Expanded Bed Adsorption Bioreactor. Prep. Biochem. Biotechnol. 2020, 50, 763–767. [Google Scholar] [CrossRef]
  103. Ahmed, S.A.; Mesbah, M.K.; Youssef, D.T. Microbial production of 1α-hydroxyvitamin D3 from vitamin D3. Nat. Prod. Res. 2014, 28, 444–448. [Google Scholar] [CrossRef] [PubMed]
  104. Zhang, Q.; Lyu, S. Microbial Interactions in a Vitamin C Industrial Fermentation System: Novel Insights and Perspectives. Appl. Env. Microbiol. 2022, 88, e0121222. [Google Scholar] [CrossRef]
  105. Ren, L.; Peng, C.; Hu, X.; Han, Y.; Huang, H. Microbial production of vitamin K2: Current status and future prospects. Biotechnol. Adv. 2020, 39, 107453. [Google Scholar] [CrossRef] [PubMed]
  106. Kang, M.-J.; Baek, K.-R.; Lee, Y.-R.; Kim, G.-H.; Seo, S.-O. Production of Vitamin K by Wild-Type and Engineered Microorganisms. Microorganisms 2022, 10, 554. [Google Scholar] [CrossRef] [PubMed]
  107. Zhang, Z.; Liu, L.; Liu, C.; Sun, Y.; Zhang, D. New aspects of microbial vitamin K2 production by expanding the product spectrum. Microb. Cell Fact. 2021, 20, 84. [Google Scholar] [CrossRef] [PubMed]
  108. Bangar, S.P.; Trif, M.; Özogul, F.; Kumar, M.; Chaudhary, V.; Vukic, M.; Tomar, M.; Changan, S. Recent developments in cold plasma-based enzyme activity (browning, cell wall degradation, and antioxidant) in fruits and vegetables. Compr. Rev. Food Sci. Food Saf. 2022, 21, 1958–1978. [Google Scholar] [CrossRef]
  109. Cavicchioli, R.; Ripple, W.J.; Timmis, K.N.; Azam, F.; Bakken, L.R.; Baylis, M.; Behrenfeld, M.J.; Boetius, A.; Boyd, P.W.; Classen, A.T.; et al. Scientists’ warning to humanity: Microorganisms and climate change. Nat. Rev. Microbiol. 2019, 17, 569–586. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  110. Pham, J.V.; Yilma, M.A.; Feliz, A.; Majid, M.T.; Maffetone, N.; Walker, J.R.; Kim, E.; Cho, H.J.; Reynolds, J.M.; Song, M.C.; et al. A Review of the Microbial Production of Bioactive Natural Products and Biologics. Front. Microbiol. 2019, 10, 1404. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  111. Roy, A.; Das, S.; Chatterjee, I.; Roy, S.; Chakraborty, R. Anti-inflammatory Effects of Different Dietary Antioxidants. In Plant Antioxidants and Health; Reference Series in Phytochemistry; Ekiert, H.M., Ramawat, K.G., Arora, J., Eds.; Springer: Cham, Switzerland, 2022. [Google Scholar] [CrossRef]
  112. Barros, L.; Ferreira, I.C.F.R. Editorial: Phytochemicals and their Effects on Human Health. Curr. Pharm. Des. 2017, 23, 2695–2696. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  113. Santhiravel, S.; Bekhit, A.E.-D.A.; Mendis, E.; Jacobs, J.L.; Dunshea, F.R.; Rajapakse, N.; Ponnampalam, E.N. The Impact of Plant Phytochemicals on the Gut Microbiota of Humans for a Balanced Life. Int. J. Mol. Sci. 2022, 23, 8124. [Google Scholar] [CrossRef] [PubMed]
  114. Mucha, P.; Skoczyńska, A.; Małecka, M.; Hikisz, P.; Budzisz, E. Overview of the Antioxidant and Anti-Inflammatory Activities of Selected Plant Compounds and Their Metal Ions Complexes. Molecules 2021, 26, 4886. [Google Scholar] [PubMed]
  115. Polat, S.; Trif, M.; Rusu, A.; Šimat, V.; Čagalj, M.; Alak, G.; Meral, R.; Özogul, Y.; Polat, A.; Özogul, F. Recent advances in industrial applications of seaweeds. Crit. Rev. Food Sci. Nutr. 2021, 8, 1–30. [Google Scholar] [CrossRef]
  116. Li, J.; Qiu, Z.; Zhao, G.R. Modular engineering of E. coli coculture for efficient production of resveratrol from glucose and arabinose mixture. Synth. Syst. Biotechnol. 2022, 7, 718–729. [Google Scholar] [CrossRef]
  117. Ibrahim, G.G.; Yan, J.; Xu, L.; Yang, M.; Yan, Y. Resveratrol Production in Yeast Hosts: Current Status and Perspectives. Biomolecules 2021, 11, 830. [Google Scholar] [CrossRef] [PubMed]
  118. Canedo-Santos, J.C.; Carrillo-Garmendia, A.; Mora-Martinez, I.; Gutierrez-Garcia, I.K.; Ramirez-Romero, M.G.; Regalado-Gonzalez, C.; Nava, G.M.; Madrigal-Perez, L.A. Resveratrol shortens the chronological lifespan of Saccharomyces cerevisiae by a pro-oxidant mechanism. Yeast 2022, 39, 193–207. [Google Scholar] [CrossRef]
  119. Meng, L.; Diao, M.; Wang, Q.; Peng, L.; Li, J.; Xie, N. Efficient biosynthesis of resveratrol via combining phenylalanine and tyrosine pathways in Saccharomyces cerevisiae. Microb. Cell Fact. 2023, 22, 46. [Google Scholar] [CrossRef] [PubMed]
  120. Luziatelli, F.; Brunetti, L.; Ficca, A.G.; Ruzzi, M. Maximizing the Efficiency of Vanillin Production by Biocatalyst Enhancement and Process Optimization. Front. Bioeng. Biotechnol. 2019, 7, 279. [Google Scholar] [CrossRef] [PubMed]
  121. Martău, G.A.; Călinoiu, L.F.; Vodnar, D.C. Bio-vanillin: Towards a sustainable industrial production. Trends Food Sci. Technol. 2021, 109, 579–592. [Google Scholar]
  122. Mark, R.; Lyu, X.; Lee, J.J.; Parra-Saldívar, R.; Chen, W.N. Sustainable production of natural phenolics for functional food applications. J. Funct. Foods 2019, 57, 233–254. [Google Scholar]
  123. Duda-Madej, A.; Stecko, J.; Sobieraj, J.; Szymańska, N.; Kozłowska, J. Naringenin and Its Derivatives—Health-Promoting Phytobiotic against Resistant Bacteria and Fungi in Humans. Antibiotics 2022, 11, 1628. [Google Scholar] [CrossRef] [PubMed]
  124. Abo-Kadoum, M.A.; Abouelela, M.E.; Al Mousa, A.A.; Abo-Dahab, N.F.; Mosa, M.A.; Helmy, Y.A.; Hassane, A.M.A. Resveratrol biosynthesis, optimization, induction, bio-transformation and bio-degradation in mycoendophytes. Front. Microbiol. 2022, 13, 1010332. [Google Scholar] [CrossRef] [PubMed]
  125. Martínez-Cámara, S.; Ibañez, A.; Rubio, S.; Barreiro, C.; Barredo, J.-L. Main Carotenoids Produced by Microorganisms. Encyclopedia 2021, 1, 1223–1245. [Google Scholar] [CrossRef]
  126. Sen, T.; Barrow, C.J.; Deshmukh, S.K. Microbial pigments in the food industry—Challenges and the way forward. Front. Nutr. 2019, 6, 7. [Google Scholar]
  127. Sankari, M.; Rao, P.R.; Hemachandran, H.; Pullela, P.K.; Tayubi, I.A.; Subramanian, B.; Gothandam, K.; Singh, P.; Ramamoorthy, S. Prospects and progress in the production of valuable carotenoids: Insights from metabolic engineering, synthetic biology, and computational approaches. J. Biotechnol. 2018, 266, 89–101. [Google Scholar] [PubMed]
  128. Rao, N.; Prabhu, M.; Xiao, M.; Li, W.J. Fungal and bacterial pigments: Secondary metabolites with wide applications. Front. Microbiol. 2017, 8, 1113. [Google Scholar]
  129. Pandey, N.; Jain, R.; Pandey, A.; Tamta, S. Optimisation and characterisation of the orange pigment produced by a cold adapted strain of Penicillium sp. (GBPI_P155) isolated from mountain ecosystem. Mycology 2018, 9, 81–92. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  130. Wu, Y.; Yan, P.; Li, Y.; Liu, X.; Wang, Z.; Chen, T.; Zhao, X. Enhancing β-Carotene Production in Escherichia coli by Perturbing Central Carbon Metabolism and Improving the NADPH Supply. Front. Bioeng. Biotechnol. 2020, 8, 585. [Google Scholar] [CrossRef]
  131. Ma, T.; Zhou, Y.; Li, X.; Zhu, F.; Cheng, Y.; Liu, Y.; Deng, Z.; Liu, T. Genome mining of astaxanthin biosynthetic genes from Sphingomonas sp. ATCC 55669 for heterologous overproduction in Escherichia coli. Biotechnol. J. 2016, 11, 228–237. [Google Scholar] [CrossRef]
  132. Tam, L.T.; Hong, D.D.; Ranga Rao, A.; Ravishankar, G.A. Astaxanthin production and technology in Vietnam and other Asian countries. In Global Perspectives on Astaxanthin. From Industrial Production to Food, Health, and Pharmaceutical Applications; Elsevier: Amsterdam, The Netherlands, 2021; pp. 595–633. [Google Scholar]
  133. Bindea, M.; Rusu, B.; Rusu, A.; Trif, M.; Leopold, L.F.; Dulf, F.; Vodnar, D.C. Valorification of crude glycerol for pure fractions of docosahexaenoic acid and beta-carotene production by using Schizochytrium limacinum and Blakeslea trispora. Microb. Cell Factories 2018, 17, 97. [Google Scholar] [CrossRef] [PubMed]
  134. Papadaki, E.; Mantzouridou, F.T. Natural β-Carotene Production by Blakeslea trispora Cultivated in Spanish-Style Green Olive Processing Wastewaters. Foods 2021, 10, 327. [Google Scholar] [CrossRef] [PubMed]
  135. Li, C.; Swofford, C.A.; Sinskey, A.J. Modular engineering for microbial production of carotenoids. Metab. Eng. Commun. 2019, 10, e00118. [Google Scholar] [CrossRef]
  136. Sandmann, G. Carotenoids and Their Biosynthesis in Fungi. Molecules 2022, 27, 1431. [Google Scholar] [CrossRef] [PubMed]
  137. Pan, X.; Wang, B.; Duan, R.; Jia, J.; Li, J.; Xiong, W.; Ling, X.; Chen, C.; Huang, X.; Zhang, G.; et al. Enhancing astaxanthin accumulation in Xanthophyllomyces dendrorhous by a phytohormone: Metabolomic and gene expression profiles. Microb. Biotechnol. 2020, 13, 1446–1460. [Google Scholar] [CrossRef] [PubMed]
  138. Naz, T.; Ullah, S.; Nazir, Y.; Li, S.; Iqbal, B.; Liu, Q.; Mohamed, H.; Song, Y. Industrially Important Fungal Carotenoids: Advancements in Biotechnological Production and Extraction. J. Fungi 2023, 9, 578. [Google Scholar]
  139. Sanmartín, P.; Bosch-Roig, P.; Pangallo, D.; Kraková, L.; Serrano, M. Unraveling disparate roles of organisms, from plants to bacteria, and viruses on built cultural heritage. Appl. Microbiol. Biotechnol. 2023, 107, 2027–2037. [Google Scholar] [CrossRef] [PubMed]
  140. Solanki, P.; Putatunda, C.; Kumar, A.; Bhatia, R.; Walia, A. Microbial proteases: Ubiquitous enzymes with innumerable uses. 3 Biotech 2021, 11, 428. [Google Scholar] [CrossRef]
  141. Yang, X.; Zhang, Y.; Pang, H.; Yuan, S.; Wang, X.; Hu, Z.; Zhou, Q.; He, Y.; Yan, Y.; Xu, L. Codisplay of Rhizopus oryzae and Candida rugosa Lipases for Biodiesel Production. Catalysts 2021, 11, 421. [Google Scholar] [CrossRef]
  142. Septiani, D.I.A.; Suryadi, H.; Mun’im, A.; Mangunwardoyo, W. Production of cellulase from Aspergillus niger and Trichoderma reesei mixed culture in carboxymethylcellulose medium as sole carbon. Biodiversitas 2019, 20, 3539–3544. [Google Scholar] [CrossRef]
  143. Haile, S.; Ayele, A. Pectinase from Microorganisms and Its Industrial Applications. Sci. World J. 2022, 2022, 1881305. [Google Scholar] [CrossRef] [PubMed]
  144. Yan, S.; Wu, G. Bottleneck in secretion of α-amylase in Bacillus subtilis. Microb. Cell Factories 2017, 16, 124. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  145. Raveendran, S.; Parameswaran, B.; Ummalyma, S.B.; Abraham, A.; Mathew, A.K.; Madhavan, A.; Rebello, S.; Pandey, A. Applications of Microbial Enzymes in Food Industry. Food Technol. Biotechnol. 2018, 56, 16–30. [Google Scholar] [CrossRef]
  146. Vachher, M.; Sen, A.; Kapila, R.; Nigam, A. Microbial therapeutic enzymes: A promising area of biopharmaceuticals. Curr. Res. Biotechnol. 2021, 3, 67–68. [Google Scholar] [CrossRef]
  147. Rodríguez-Sáiz, M.; de la Fuente, J.L.; Barredo, J.L. Xanthophyllomyces dendrorhous for the industrial production of astaxanthin. Appl. Microbiol. Biotechnol. 2010, 88, 645–658. [Google Scholar]
  148. Wang, E.; Dong, C.; Zhang, P.; Roberts, T.H.; Park, R.F. Carotenoid biosynthesis and the evolution of carotenogenesis genes in rust fungi. Fungal Biol. 2021, 125, 400–411. [Google Scholar] [CrossRef] [PubMed]
  149. Mohanty, S.S.; Koul, Y.; Varjani, S.; Pandey, A.; Ngo, H.H.; Chang, J.-S.; Wong, J.W.C.; Bui, X.-T. A critical review on various feedstocks as sustainable substrates for biosurfactants production: A way towards cleaner production. Microb. Cell Factories 2021, 20, 120. [Google Scholar] [CrossRef]
  150. Rinke, C.; Schwientek, P.; Sczyrba, A.; Ivanova, N.N.; Anderson, I.J.; Cheng, J.-F.; Darling, A.; Malfatti, S.; Swan, B.K.; Gies, E.A.; et al. Insights into the phylogeny and coding potential of microbial dark matter. Nature 2013, 499, 431–437. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  151. Sreenikethanam, A.; Raj, S.; Banu, J.R.; Gugulothu, P.; Bajhaiya, A.K. Genetic Engineering of Microalgae for Secondary Metabolite Production: Recent Developments, Challenges, and Future Prospects. Front. Bioeng. Biotechnol. 2022, 10, 836056. [Google Scholar] [CrossRef] [PubMed]
  152. Graham, A.E.; Ledesma-Amaro, R. The microbial food revolution. Nat. Commun. 2023, 14, 2231. [Google Scholar] [CrossRef]
  153. Afzaal, M.; Saeed, F.; Shah, Y.A.; Hussain, M.; Rabail, R.; Socol, C.T.; Hassoun, A.; Pateiro, M.; Lorenzo, J.M.; Rusu, A.V.; et al. Human gut microbiota in health and disease: Unveiling the relationship. Front. Microbiol. 2022, 13, 999001. [Google Scholar] [PubMed]
  154. Kim, S.-H.; Kuo, W.-Y. The Role of Beliefs, Pride, and Perceived Barriers in Decision-Making Regarding Purchasing Value-Added Pulse Products among US Consumers. Foods 2022, 11, 824. [Google Scholar] [CrossRef]
  155. Singh, G.P.; Bangar, S.P.; Yang, T.; Trif, M.; Kumar, V.; Kumar, D. Effect on the Properties of Edible Starch-Based Films by the Incorporation of Additives: A Review. Polymers 2022, 14, 1987. [Google Scholar] [PubMed]
  156. Siegrist, M.; Hartmann, C. Consumer acceptance of novel food technologies. Nat. Food 2020, 1, 343–350. [Google Scholar] [CrossRef] [PubMed]
  157. Hassoun, A.; Jagtap, S.; Garcia-Garcia, G.; Trollman, H.; Pateiro, M.; Lorenzo, J.M.; Trif, M.; Rusu, A.V.; Aadil, R.M.; Šimat, V.; et al. Food quality 4.0: From traditional approaches to digitalized automated analysis. J. Food Eng. 2022, 337, 111216. [Google Scholar] [CrossRef]
Figure 1. Key points to know about dietary supplements.
Figure 1. Key points to know about dietary supplements.
Molecules 28 06020 g001
Figure 2. Biotechnological approaches to produce microbial secondary metabolites.
Figure 2. Biotechnological approaches to produce microbial secondary metabolites.
Molecules 28 06020 g002
Figure 3. Factors influencing consumers’ acceptance of dietary supplementation.
Figure 3. Factors influencing consumers’ acceptance of dietary supplementation.
Molecules 28 06020 g003
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Rusu, A.V.; Trif, M.; Rocha, J.M. Microbial Secondary Metabolites via Fermentation Approaches for Dietary Supplementation Formulations. Molecules 2023, 28, 6020. https://doi.org/10.3390/molecules28166020

AMA Style

Rusu AV, Trif M, Rocha JM. Microbial Secondary Metabolites via Fermentation Approaches for Dietary Supplementation Formulations. Molecules. 2023; 28(16):6020. https://doi.org/10.3390/molecules28166020

Chicago/Turabian Style

Rusu, Alexandru Vasile, Monica Trif, and João Miguel Rocha. 2023. "Microbial Secondary Metabolites via Fermentation Approaches for Dietary Supplementation Formulations" Molecules 28, no. 16: 6020. https://doi.org/10.3390/molecules28166020

Article Metrics

Back to TopTop